Contemporary trends on expenditure of hospital care on total cancer and its subtypes in China during 2008−2017

Cai, Yue; Chen, Wanqing; Wang, Xiaoxu; Xia, Xue; Cui, Xiang; Wu, Shiyong; Liu, Jinghua

doi:10.21147/j.issn.1000-9604.2021.05.09

Cited by 20 publications

(13 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In 2015, China had an estimated 733,300 newly diagnosed and 610,200 death cases 18,19 . Additionally, lung cancer is the most expensive cancer to treat and imposes an enormous financial burden on individuals and families 20–22 . Previous studies among patients with lung cancer indicated negative consequences and identified some predictors of FT. For example, Hazell et al reported that FT was associated with poorer quality of life and that work status was a predictor in the United States 23 .…”

Section: Introductionmentioning

confidence: 99%

“… 18 , 19 Additionally, lung cancer is the most expensive cancer to treat and imposes an enormous financial burden on individuals and families. 20 , 21 , 22 Previous studies among patients with lung cancer indicated negative consequences and identified some predictors of FT. For example, Hazell et al reported that FT was associated with poorer quality of life and that work status was a predictor in the United States. 23 Ezeife et al found that age, work, insurance, aid, clinical trials, and out‐of‐pocket costs were predictors in Canada.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Financial toxicity of patients with lung cancer in China: Results from a National Survey Study

2022

View full text Add to dashboard Cite

Financial toxicity (FT) refers to the subjective financial distress and objective financial burden of medical care expenditures. 1 An increasing amount of attention has been paid to FT in patients with cancer, in large part due to the rising costs of cancer diagnosis and treatment. 2 Previous studies of FT in cancer patients have examined the prevalence of FT among subgroups of patients with different cancer types, 3-6 cancer stages, 5,7,8 treatment schemes, 5,9 healthcare coverage systems, [10][11][12] or other subgroups as well as related factors of FT. These studies indicated

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Financial toxicity of patients with lung cancer in China: Results from a National Survey Study

2022

View full text Add to dashboard Cite

show abstract

“…The cost of hospitalization for CRC has risen the fastest since 2008 [7]. In 2014, the average medical expenditure of CRC was $12850, which is higher than that of breast cancer ($8892) [8].…”

Section: Introductionmentioning

confidence: 99%

Research on return to work for colorectal cancer survivors: A bibliometric analysis

Zhang

Wang

et al. 2023

Preprint

View full text Add to dashboard Cite

Purpose Colorectal cancer survivors’ returning to work is a symbol of recovery as well as back to society. However, few studies have explored the study orientation for this domain. A bibliometric analysis of this field is urgently needed. Methods The database of Web of Science Core Collection was utilized to search publications. Characteristics of literature including publication years, countries, institutions, journals and authors were analyzed. VOSviewer and CiteSpace were utilized for data visualization. The data search and analysis were conducted on May 11, 2022. Results Totally, 125 articles were identified. The article number has grown gradually in the last twenty years. The League of European Research Universities and author De Boer Agem from the Netherlands contribute most in this field. The Journal of Supportive Care In Cancer issued the utmost articles, and the journal of Psycho Oncology outranked other journals with citations suggesting that it serves as the landmark journal. Outcomes, employment & financial burden, health & barriers and quality of life & rehabilitation are high-frequency keywords in co-occurrence analysis. Burst analysis revealed that experience, financial burden, risk factors, symptoms distress (fatigue), unemployment and physical activity studies were the emerging hot spots in the domain. The management of return to work after colorectal cancer is multidisciplinary. Conclusions The understanding of returning to work for colorectal cancer patients has improved increasingly over the two decades. The author De Boer Agem from the Netherlands and the Journal of Supportive Care In Cancer made the largest contribution to this domain. More attention should be paid to experience, financial burden, risk factors, symptoms of distress (fatigue), unemployment, and intervention studies. Multidisciplinary integration is the essence.

show abstract

“…Lung cancer ranks first in both incidence and mortality among all cancers in China (1), and has caused heavy disease and economic burden on the Chinese population (2,3). The prognosis of lung cancer patients was poor, with the 5-year survival rates less than 20% (4)(5)(6).…”

Section: Introductionmentioning

confidence: 99%

Survival of 7,311 lung cancer patients by pathological stage and histological classification: a multicenter hospital-based study in China

He¹,

Li²,

Cao³

et al. 2022

Transl Lung Cancer Res

Self Cite

View full text Add to dashboard Cite

Background: Representative prognostic data by clinical characteristics for lung cancer is not yet available in China. This study aimed to calculate the survival of lung cancer patients with different pathological evaluations, explore their predictive effects and provide information for prognosis improvement. Methods:In this multicenter cohort study, primary lung cancer patients diagnosed in 17 hospitals at three distinct levels in China between 2011-2013 were enrolled and followed up till 2020. Overall survival and lung cancer specific survival were calculated by Kaplan-Meier method. Cox proportional hazards model was applied to assess the effects of predictors of lung cancer survival.Results: Of all the 7,311 patients, the 5-year overall and lung cancer specific survival rates were 37.0% and 41.6%, respectively. For lung cancer patients at stages I, II, III, and IV, the 5-year overall survival rates were 76.9%, 56.1%, 32.6%, and 21.4%, respectively; the lung cancer specific survival rates were 82.3%, 59.7%, 37.2%, and 26.4%, respectively. Differences of survival for each stage remained significant between histological classifications (P<0.01). The 5-year overall survival rates for patients with squamous cell carcinoma, adenocarcinoma (AC), and small cell carcinoma were 36.9%, 43.3% and 27.9%, respectively; the corresponding disease-specific rates were 41.5%, 48.6% and 31.0%, respectively. Such differences were nonstatistically significant at advanced stages (P=0.09). After multivariate adjustments, stage and classification remained independent predictors for the survival of lung cancer. Conclusions:The prognosis of lung cancer varied with the pathological stages and histological classifications, and had room for improvement. Stage was the strongest predictor, so efforts on early detection and treatment are needed.

show abstract

Contemporary trends on expenditure of hospital care on total cancer and its subtypes in China during 2008−2017

Cited by 20 publications

References 17 publications

Financial toxicity of patients with lung cancer in China: Results from a National Survey Study

Financial toxicity of patients with lung cancer in China: Results from a National Survey Study

Research on return to work for colorectal cancer survivors: A bibliometric analysis

Survival of 7,311 lung cancer patients by pathological stage and histological classification: a multicenter hospital-based study in China

Contact Info

Product

Resources

About